These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24929472)

  • 1. Effect of ferrocene-substituted porphyrin RL-91 on Candida albicans biofilm formation.
    Lippert R; Vojnovic S; Mitrovic A; Jux N; Ivanović-Burmazović I; Vasiljevic B; Stankovic N
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3506-11. PubMed ID: 24929472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilising polyphenols for the clinical management of Candida albicans biofilms.
    Shahzad M; Sherry L; Rajendran R; Edwards CA; Combet E; Ramage G
    Int J Antimicrob Agents; 2014 Sep; 44(3):269-73. PubMed ID: 25104135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocol for Determination of the Persister Subpopulation in Candida Albicans Biofilms.
    De Brucker K; De Cremer K; Cammue BP; Thevissen K
    Methods Mol Biol; 2016; 1333():67-72. PubMed ID: 26468100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of alkylphospholipids on Candida albicans biofilm formation and maturation.
    Vila TV; Ishida K; de Souza W; Prousis K; Calogeropoulou T; Rozental S
    J Antimicrob Chemother; 2013 Jan; 68(1):113-25. PubMed ID: 22995097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymol inhibits Candida albicans biofilm formation and mature biofilm.
    Braga PC; Culici M; Alfieri M; Dal Sasso M
    Int J Antimicrob Agents; 2008 May; 31(5):472-7. PubMed ID: 18329858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans.
    Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ
    Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic activity of lysozyme and antifungal agents against Candida albicans biofilms on denture acrylic surfaces.
    Samaranayake YH; Cheung BP; Parahitiyawa N; Seneviratne CJ; Yau JY; Yeung KW; Samaranayake LP
    Arch Oral Biol; 2009 Feb; 54(2):115-26. PubMed ID: 19038377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fungicidal photodynamic effect of a twofold positively charged porphyrin against Candida albicans planktonic cells and biofilms.
    Gonzales FP; Felgenträger A; Bäumler W; Maisch T
    Future Microbiol; 2013 Jun; 8(6):785-97. PubMed ID: 23701333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexplored antifungal activity of linear battacin lipopeptides against planktonic and mature biofilms of C. albicans.
    De Zoysa GH; Glossop HD; Sarojini V
    Eur J Med Chem; 2018 Feb; 146():344-353. PubMed ID: 29407961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The radish defensins RsAFP1 and RsAFP2 act synergistically with caspofungin against Candida albicans biofilms.
    Vriens K; Cools TL; Harvey PJ; Craik DJ; Braem A; Vleugels J; De Coninck B; Cammue BP; Thevissen K
    Peptides; 2016 Jan; 75():71-9. PubMed ID: 26592804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening the Pathogen Box for Identification of Candida albicans Biofilm Inhibitors.
    Vila T; Lopez-Ribot JL
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of Candida biofilms to histatin 5 and fluconazole.
    Konopka K; Dorocka-Bobkowska B; Gebremedhin S; Düzgüneş N
    Antonie Van Leeuwenhoek; 2010 May; 97(4):413-7. PubMed ID: 20140514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commercial mouthwashes are more effective than azole antifungals against Candida albicans biofilms in vitro.
    Ramage G; Jose A; Coco B; Rajendran R; Rautemaa R; Murray C; Lappin DF; Bagg J
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Apr; 111(4):456-60. PubMed ID: 21310633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Candida albicans biofilm formation and yeast-hyphal transition by 4-hydroxycordoin.
    Messier C; Epifano F; Genovese S; Grenier D
    Phytomedicine; 2011 Mar; 18(5):380-3. PubMed ID: 21353508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans.
    Messier C; Grenier D
    Mycoses; 2011 Nov; 54(6):e801-6. PubMed ID: 21615543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Organochalcogen Compound (MeOPhSe)2 Inhibits Both Formation and the Viability of the Biofilm Produced by Candida albicans, at Different Stages of Development.
    de Amorim LMM; Braga MT; Carvalho ML; de Oliveira IR; Querobino SM; Alberto-Silva C; da Rocha JBT; Costa MS
    Curr Pharm Des; 2018; 24(33):3964-3971. PubMed ID: 30465492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tramadol, an Opioid Receptor Agonist: An Inhibitor of Growth, Morphogenesis, and Biofilm Formation in the Human Pathogen, Candida albicans.
    Kathwate GH; Karuppayil SM
    Assay Drug Dev Technol; 2016 Dec; 14(10):567-572. PubMed ID: 27982704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of Candida albicans biofilms to azithromycin, tigecycline and vancomycin and the interaction between tigecycline and antifungals.
    Ku TS; Palanisamy SK; Lee SA
    Int J Antimicrob Agents; 2010 Nov; 36(5):441-6. PubMed ID: 20685088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-biofilm activity of the metabolites of Streptomyces chrestomyceticus strain ADP4 against Candida albicans.
    Srivastava V; Dubey AK
    J Biosci Bioeng; 2016 Oct; 122(4):434-40. PubMed ID: 27117484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terpenoids of plant origin inhibit morphogenesis, adhesion, and biofilm formation by Candida albicans.
    Raut JS; Shinde RB; Chauhan NM; Karuppayil SM
    Biofouling; 2013; 29(1):87-96. PubMed ID: 23216018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.